Global Immunology Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12241960

Publication Date:

December 17, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Immunology market size was valued at US$ 62840 million in 2023. With growing demand in downstream market, the Immunology is forecast to a readjusted size of US$ 99220 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Immunology market. Immunology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immunology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immunology market.
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
Key Features:
The report on Immunology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immunology market. It may include historical data, market segmentation by Type (e.g., Immuno Boosters, Immunosuppressants), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immunology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immunology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immunology industry. This include advancements in Immunology technology, Immunology new entrants, Immunology new investment, and other innovations that are shaping the future of Immunology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immunology market. It includes factors influencing customer ' purchasing decisions, preferences for Immunology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immunology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immunology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immunology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immunology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immunology market.
Market Segmentation:
Immunology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Immuno Boosters
Immunosuppressants
Segmentation by application
Autoimmune Diseases
Oncology
Organ Transplantation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunology Market Size 2019-2030
2.1.2 Immunology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immunology Segment by Type
2.2.1 Immuno Boosters
2.2.2 Immunosuppressants
2.3 Immunology Market Size by Type
2.3.1 Immunology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immunology Market Size Market Share by Type (2019-2024)
2.4 Immunology Segment by Application
2.4.1 Autoimmune Diseases
2.4.2 Oncology
2.4.3 Organ Transplantation
2.4.4 Others
2.5 Immunology Market Size by Application
2.5.1 Immunology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immunology Market Size Market Share by Application (2019-2024)
3 Immunology Market Size by Player
3.1 Immunology Market Size Market Share by Players
3.1.1 Global Immunology Revenue by Players (2019-2024)
3.1.2 Global Immunology Revenue Market Share by Players (2019-2024)
3.2 Global Immunology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immunology by Regions
4.1 Immunology Market Size by Regions (2019-2024)
4.2 Americas Immunology Market Size Growth (2019-2024)
4.3 APAC Immunology Market Size Growth (2019-2024)
4.4 Europe Immunology Market Size Growth (2019-2024)
4.5 Middle East & Africa Immunology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Immunology Market Size by Country (2019-2024)
5.2 Americas Immunology Market Size by Type (2019-2024)
5.3 Americas Immunology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunology Market Size by Region (2019-2024)
6.2 APAC Immunology Market Size by Type (2019-2024)
6.3 APAC Immunology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immunology by Country (2019-2024)
7.2 Europe Immunology Market Size by Type (2019-2024)
7.3 Europe Immunology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunology by Region (2019-2024)
8.2 Middle East & Africa Immunology Market Size by Type (2019-2024)
8.3 Middle East & Africa Immunology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immunology Market Forecast
10.1 Global Immunology Forecast by Regions (2025-2030)
10.1.1 Global Immunology Forecast by Regions (2025-2030)
10.1.2 Americas Immunology Forecast
10.1.3 APAC Immunology Forecast
10.1.4 Europe Immunology Forecast
10.1.5 Middle East & Africa Immunology Forecast
10.2 Americas Immunology Forecast by Country (2025-2030)
10.2.1 United States Immunology Market Forecast
10.2.2 Canada Immunology Market Forecast
10.2.3 Mexico Immunology Market Forecast
10.2.4 Brazil Immunology Market Forecast
10.3 APAC Immunology Forecast by Region (2025-2030)
10.3.1 China Immunology Market Forecast
10.3.2 Japan Immunology Market Forecast
10.3.3 Korea Immunology Market Forecast
10.3.4 Southeast Asia Immunology Market Forecast
10.3.5 India Immunology Market Forecast
10.3.6 Australia Immunology Market Forecast
10.4 Europe Immunology Forecast by Country (2025-2030)
10.4.1 Germany Immunology Market Forecast
10.4.2 France Immunology Market Forecast
10.4.3 UK Immunology Market Forecast
10.4.4 Italy Immunology Market Forecast
10.4.5 Russia Immunology Market Forecast
10.5 Middle East & Africa Immunology Forecast by Region (2025-2030)
10.5.1 Egypt Immunology Market Forecast
10.5.2 South Africa Immunology Market Forecast
10.5.3 Israel Immunology Market Forecast
10.5.4 Turkey Immunology Market Forecast
10.5.5 GCC Countries Immunology Market Forecast
10.6 Global Immunology Forecast by Type (2025-2030)
10.7 Global Immunology Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Immunology Product Offered
11.1.3 AbbVie Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Immunology Product Offered
11.2.3 Amgen Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Information
11.3.2 F. Hoffmann-La Roche Immunology Product Offered
11.3.3 F. Hoffmann-La Roche Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann-La Roche Main Business Overview
11.3.5 F. Hoffmann-La Roche Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Immunology Product Offered
11.4.3 Johnson & Johnson Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Bionor Pharma
11.5.1 Bionor Pharma Company Information
11.5.2 Bionor Pharma Immunology Product Offered
11.5.3 Bionor Pharma Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bionor Pharma Main Business Overview
11.5.5 Bionor Pharma Latest Developments
11.6 Celgene
11.6.1 Celgene Company Information
11.6.2 Celgene Immunology Product Offered
11.6.3 Celgene Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Main Business Overview
11.6.5 Celgene Latest Developments
11.7 Cellectar Biosciences
11.7.1 Cellectar Biosciences Company Information
11.7.2 Cellectar Biosciences Immunology Product Offered
11.7.3 Cellectar Biosciences Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cellectar Biosciences Main Business Overview
11.7.5 Cellectar Biosciences Latest Developments
11.8 eFFECTOR Therapeutics
11.8.1 eFFECTOR Therapeutics Company Information
11.8.2 eFFECTOR Therapeutics Immunology Product Offered
11.8.3 eFFECTOR Therapeutics Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 eFFECTOR Therapeutics Main Business Overview
11.8.5 eFFECTOR Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂